Jim Tananbaum, Foresite Capital founder and CEO
Foresite Capital closes $900M sixth fund, backing the likes of Xaira and IPO hopeful Alumis
Foresite Capital, fresh off one of the largest-ever biotech launches, has closed on its sixth fund just 13 years into its life …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
